The FirstTake Podcast – Will vaccine sales prime Pfizer for deal-making?

FirstTake on Pharma - Pharma News and Analysis Podcast

English - May 27, 2021 19:00 - 21 minutes - 13.6 MB - ★★★★★ - 2 ratings
Science pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The FirstTake Podcast – ASCO abstracts drop

Next Episode: The FirstTake Podcast – KRAS, OX40, EQRx and ASCO in focus

FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss whether soaring revenue projections for Pfizer’s COVID-19 vaccine will position the company as an aggressive deal-maker, assess yet another setback in the once-promising field of NASH and cast an eye over the potential opportunity for Cabometyx as a new treatment option for prostate cancer.